Table 5 Results of cost utility analysis: base-case
• Treatment | iStent inject® + cataract surgery | Cataract surgery |
|---|---|---|
Costs (€) | ||
• Procedures (€) | € 3557.00 | € 2317.06 |
• Medications (€) | €25.59 | €51.17 |
• Progression-related (€) | €4691.45 | €4765.25 |
• Adverse events (€) | €94.46 | €1.22 |
• Total costs (€) | €8368.51 | €7134.71 |
• Efficacy | ||
• Survival (life years, LYs) | • 14.575 | • 14.575 |
• Quality of life adjusted survival (QALY) | • 11.114 | • 11.019 |
• Incremental outcomes (iStent inject® + cataract surgery vs. cataract surgery alone) | ||
• Incremental costs (€) | • €1233.80 | |
• Incremental LYs | • – | |
• Incremental QALYs | • 0.095 | |
• ICER (€/QALY) | • €13,037/QALY | |